APA (7th ed.) Citation

Palmarocchi, M. C., Cefali, M., Galante, A., Rizzo, S., & Dosso, S. D. (2022). Benefits and Complications Following First-Line Treatment with Atezolizumab plus Bevacizumab in a Patient with HCC: A Case Report. THE HEALTHBOOK COMPANY LTD.

Chicago Style (17th ed.) Citation

Palmarocchi, Maria Celeste, Marco Cefali, Antonio Galante, Stefania Rizzo, and Sara De Dosso. Benefits and Complications Following First-Line Treatment with Atezolizumab Plus Bevacizumab in a Patient with HCC: A Case Report. THE HEALTHBOOK COMPANY LTD, 2022.

MLA (9th ed.) Citation

Palmarocchi, Maria Celeste, et al. Benefits and Complications Following First-Line Treatment with Atezolizumab Plus Bevacizumab in a Patient with HCC: A Case Report. THE HEALTHBOOK COMPANY LTD, 2022.